DEUTSCHE BANK AG\ - CHINA PHARMA HLDGS INC ownership

CHINA PHARMA HLDGS INC's ticker is CPHI and the CUSIP is 16941T104. A total of 8 filers reported holding CHINA PHARMA HLDGS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of CHINA PHARMA HLDGS INC
ValueSharesWeighting
Q4 2019$1,000
-95.8%
6,255
-91.6%
0.00%
Q2 2019$24,000
-66.2%
74,720
-65.2%
0.00%
Q1 2019$71,000214,9000.00%
Other shareholders
CHINA PHARMA HLDGS INC shareholders Q4 2019
NameSharesValueWeighting ↓
GLENHILL ADVISORS LLC 200,000$44,0000.22%
PANAGORA ASSET MANAGEMENT INC 132,903$29,0000.00%
Citadel Advisors 60,859$13,0000.00%
JOYN Advisors, Inc. 100$00.00%
Bogart Wealth, LLC 1,000$00.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 25,004$5,0000.00%
Virtu Financial LLC 14,633$3,0000.00%
Renaissance Technologies 1,091,792$297,0000.00%
PARSONS CAPITAL MANAGEMENT INC/RI 10,000$2,0000.00%
UBS Group AG 9,200$2,0000.00%
View complete list of CHINA PHARMA HLDGS INC shareholders